Page last updated: 2024-11-04

rofecoxib and Hemophilia B

rofecoxib has been researched along with Hemophilia B in 1 studies

Hemophilia B: A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)

Research Excerpts

ExcerptRelevanceReference
"Rofecoxib was used for eight acute haemarthrosis, four target joints, seven cases of synovitis and 12 episodes of pain."1.33Rofecoxib as adjunctive therapy for haemophilic arthropathy. ( Nugent, DJ; Rattray, B; Young, G, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rattray, B1
Nugent, DJ1
Young, G1

Other Studies

1 other study available for rofecoxib and Hemophilia B

ArticleYear
Rofecoxib as adjunctive therapy for haemophilic arthropathy.
    Haemophilia : the official journal of the World Federation of Hemophilia, 2005, Volume: 11, Issue:3

    Topics: Acute Disease; Adjuvants, Pharmaceutic; Administration, Oral; Adolescent; Adult; Anti-Inflammatory A

2005